# Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic Stroke

> **NCT05850208** · PHASE1 · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Transplantation of self BMSCs

## Key facts

- **NCT ID:** NCT05850208
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-23
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05850208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05850208, "Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05850208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*